Summary
It has been suggested that increased glucose/glucose 6-phosphate substrate cycling impairs net hepatic glucose uptake in Type 2 (non-insulin-dependent) diabetes mellitus and contributes to hyperglycaemia. To investigate glucose/glucose 6-phosphate cycle activity and insulin action in Type 2 diabetes we studied eight patients and eight healthy control subjects, using the euglycaemic glucose clamp and isotope dilution techniques with purified [2-3H]- and [6-3H] glucose tracers, in the post-absorptive state and eight patients and five healthy control subjects during consecutive insulin infusions at rates of 0.4 and 2.0 mU·kg−1·min−1. [2-3H]glucose and [6-3H]glucose radioactivity in plasma samples were determined using selective enzymatic detritiation, allowing calculation of glucose turnover rates for each isotope, the difference being glucose/glucose 6-phosphate cycling. Endogenous glucose production ([6-3H]glucose) was greater in diabetic than control subjects in the post-absorptive state (15.6±1.5 vs 11.3±0.4 μmol·kg−1·min−1, p<0.05) and during the 0.4 mU insulin infusion (10.1±1.3 vs 5.2±0.3 μmol·kg−1·min−1, p<0.01) indicating hepatic insulin resistance. Glucose/glucose 6-phosphate cycling was significantly greater in diabetic than in control subjects in the post-absorptive state (2.6±0.4 vs 1.6±0.2 μmol·kg−1·min−1, p<0.05) but not during the 0.4 mU insulin infusion (2.0±0.4 vs 2.0±0.3 μmol·kg−1·min−1). During the 2.0 mU insulin infusion endogenous glucose production was suppressed to a similar degree in both groups (2.6±0.5 vs 3.4±0.7 μmol · kg−1·min−1) but glucose disappearance was lower in the diabetic subjects (30.8±2.0 vs 52.4±4.6 μmol·kg−1·min−1, p<0.01). During the 2.0 mU insulin infusion glucose/glucose 6-phosphate cycling was greater in the diabetic subjects (3.8±0.7 vs 0.8±0.6 μmol·kg−1·min−1, p<0.05). In conclusion, both hepatic and peripheral insulin action are impaired in Type 2 diabetes. Increased glucose/glucose 6-phosphate cycling is seen in the post-absorptive state and also during marked hyperinsulinaemia, when insulin resistance is predominantly due to reduced peripheral tissue glucose uptake.
Article PDF
Similar content being viewed by others
References
Reaven GM, Chen Y-DI, Donner CC, Fraze E, Hollenbeck CB (1985) How insulin resistant are patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 61: 32–36
Firth R, Bell PM, Rizza RA (1987) Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. Metabolism 36: 1091–1095
Campbell PJ, Mandarino LJ, Gerich JE (1988) Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 37: 15–21
Butler PC, Kryshak EJ, Schwenk WF, Haymond MW, Rizza RA (1990) Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Assessment in absence of artifact introduced by tritiated nonglucose contaminants. Diabetes 39: 217–225
McGarry JD, Kuvoajima M, Newgard CB, Foster DW (1987) From dietary glucose to liver glycogen: the full circle round. Annu Rev Nutr 7: 51–73
Katz J, Rognstad R (1976) Futile cycles in the metabolism of glucose. Curr Top Cell Regul 10: 237–289
Efendic S, Karlander S, Vranic M (1988) Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity. J Clin Invest 81: 1953–1961
Neely RDG, Rooney DP, Atkinson AB, Sheridan B, Ennis CN, Trimble ER, Bell PM (1990) Underestimation of glucose turn-over determined using [6-3H]glucose in non-steady state. The role of a tritiated tracer impurity. Diabetologia 33: 681–687
Rooney DP, Neely RDG, Ennis CN, Bell NP, Sheridan B, Atkinson AB, Trimble ER, Bell PM (1992) Insulin action and hepatic glucose cycling in essential hypertension. Metabolism 41: 317–324
Levy JC, Brown G, Matthews DR, Turner RC (1989) Hepatic glucose output in humans measured with labeled glucose to reduce negative errors. Am J Physiol 257: E531-E540
Somogyi M (1945) Determination of blood sugar. J Biol Chem 160: 69–73
Issekutz B (1977) Studies on hepatic glucose cycles in normal and methylprednisolone treated dogs. Metabolism 26: 157–170
Hales CN, Randle PJ (1963) Immunoassay of insulin with insulin antibody precipitate. Biochem J 88: 137–146
Steele R, Wall JS, De Bodo RC, Altszuler N (1956) Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 187: 15–25
De Bodo RC, Steele R, Altszuler N, Dunn A, Bishop JS (1963) On the hormonal regulation of carbohydrate metabolism: studies with C14 glucose. Rec Prog Horm Res 19: 445–448
Karlander S, Roovete A, Vranic M, Efendic S (1986) Glucose and fructose 6-phosphate cycle in humans. Am J Physiol 251: E530-E536
Capaldo B, Santoro D, Riccardi G, Perrotti N, Sacca L (1987) Direct evidence for a stimulatory effect of hyperglycaemia per se on peripheral glucose disposal in type 2 diabetes. J Clin Invest 77: 1285–1290
Butler PC, Rizza RA (1991) Contribution to postprandial hyperglycaemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients. Diabetes 40: 73–81
Nordlie R (1974) Metabolic regulation by multifunctional glucose-6-phosphatase. Curr Top Cell Regul 8: 33–117
Williamson JR, Kreisberg RA, Felts PW (1966) Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci USA 56: 247–254
Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen M-R, Groop L (1991) Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34: 409–415
Liljenquist JE, Mueller GL, Cherrington AD et al. (1977) Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man. J Clin Invest 59: 369–374
Raskin P, Unger RH (1978) Hyperglucagonaemia and its suppression, importance in the metabolic control of diabetes. N Engl J Med 299: 433–436
Lickley H, Kemmer F, El-Tayeb K, Vranic M (1987) Importance of glucagon in the control of futile cycling as studied in alloxan-diabetic dogs. Diabetologia 30: 175–182
Miyoshi H, Shulman G, Peters E, Wolfe M, Elahi D, Wolfe R (1988) Hormonal control of substrate cycling in humans. J Clin Invest 81: 1545–1555
Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914–924
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rooney, D.P., Neely, R.D.G., Beatty, O. et al. Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36, 106–112 (1993). https://doi.org/10.1007/BF00400689
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400689